期刊
CNS NEUROSCIENCE & THERAPEUTICS
卷 21, 期 8, 页码 642-650出版社
WILEY-BLACKWELL
DOI: 10.1111/cns.12416
关键词
Epilepsy; Inflammation; Interleukin-1 beta; Interleukin-1 Receptor Type I; Seizures
资金
- National Natural Science Foundation of China [91332202, 81273492, 81302749]
- China Science Fund for Creative Research Groups [81221003]
- Program for Zhejiang Leading Team of ST Innovation [2011R50014]
AimsThe postictal suppression (PS) is a common and important period following an epileptic seizure but has not been well studied. This study was designed to determine whether interleukin-1 (IL-1) is involved in the PS. MethodsThe effects of IL-1 on the PS were tested in three independent seizure models induced by hippocampal kindling, maximal electroshock seizure (MES), and 4-aminopyridine, respectively. ResultsIL-1R1 knockout or IL-1RA enhanced the seizure refractory phenomenon without influencing the baseline seizure threshold in intermittent MES model. IL-1 attenuated the seizure refractory phenomenon without affecting the severity of the preceding seizures in hippocampal kindling model, while IL-1RA enhanced it. Besides, IL-1 reduced the postictal EEG suppression period, while IL-1RA prolonged it. And IL-1 showed no further effect on the postictal EEG suppression and seizure refractory phenomenon in IL-1R1 knockout mice. In addition, 30min after intrahippocampal injection of 4-aminopyridine, IL-1 increased the incidence of SE, while IL-1RA prolonged the intervals between recurrent seizures. ConclusionsThis study provides the first direct evidence that IL-1 is key regulatory factor for the PS, and its receptor IL-1R1 may be a potential target for adjuvant treatment of postictal problems.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据